Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0000897069-23-001044

10% owner sold 94,298 shares at an average $1.41 ($133,114)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Priebe Waldemar 10% owner 2022-12-06 Sale 10b5-1 −5,500 $2.47 $13,585 245,605 I
Priebe Waldemar 10% owner 2022-12-07 Sale 10b5-1 −5,500 $2.46 $13,530 240,105 I
Priebe Waldemar 10% owner 2022-12-08 Sale 10b5-1 −5,500 $2.40 $13,200 234,605 I
Priebe Waldemar 10% owner 2022-12-09 Sale 10b5-1 −2,798 $2.43 $6,799 231,807 I
Priebe Waldemar 10% owner 2023-03-10 Sale 10b5-1 −5,000 $1.29 $6,450 226,807 I
Priebe Waldemar 10% owner 2023-03-13 Sale 10b5-1 −5,000 $1.30 $6,500 221,807 I
Priebe Waldemar 10% owner 2023-03-14 Sale 10b5-1 −5,000 $1.35 $6,750 216,807 I
Priebe Waldemar 10% owner 2023-03-15 Sale 10b5-1 −5,000 $1.22 $6,100 211,807 I
Priebe Waldemar 10% owner 2023-03-16 Sale 10b5-1 −5,000 $1.24 $6,200 206,807 I
Priebe Waldemar 10% owner 2023-03-17 Sale 10b5-1 −5,000 $1.13 $5,650 201,807 I
Priebe Waldemar 10% owner 2023-03-20 Sale 10b5-1 −5,000 $1.08 $5,400 196,807 I
Priebe Waldemar 10% owner 2023-03-21 Sale 10b5-1 −5,000 $1.10 $5,500 191,807 I
Priebe Waldemar 10% owner 2023-03-22 Sale 10b5-1 −5,000 $1.08 $5,400 186,807 I
Priebe Waldemar 10% owner 2023-03-23 Sale 10b5-1 −10,000 $1.08 $10,800 176,807 I
Priebe Waldemar 10% owner 2023-03-24 Sale 10b5-1 −5,000 $1.08 $5,400 171,807 I
Priebe Waldemar 10% owner 2023-03-27 Sale 10b5-1 −5,000 $1.09 $5,450 166,807 I
Priebe Waldemar 10% owner 2023-03-28 Sale 10b5-1 −10,000 $1.04 $10,400 156,807 I
Open-market sales · 94,298 sh · avg $1.41 · $133,114
Loading xslF345X05/form4.xml…